基于蛋白质组学绘制支气管肺发育不良相关口腔分泌物变化图谱
该回顾性单中心队列研究对胎龄<32周早产儿第3周龄的口腔分泌物与气管吸出物进行高通量蛋白质组学比较,发现口腔分泌物含607种特有蛋白,并鉴定出37种与支气管肺发育不良(BPD)显著差异丰度的口腔蛋白,提示口腔分泌物可作为无创替代样本寻找BPD生物标志物。
要点
- 口腔分泌物与气管吸出物蛋白组有687种重叠蛋白,涉及免疫效应和中性粒细胞脱颗粒等通路。
- 37种口腔蛋白在BPD病例与对照间丰度显著差异,其中10种此前已在血或气管吸出物中与BPD或早产相关肺病关联。
- 口腔分泌物是无创、易获取的样本,适用于早产儿高通量蛋白质组学分析。
核心结论
- 口腔分泌物是无创、易获取的替代气管吸出物的样本,可用于早产儿高通量蛋白质组学分析。
- 口腔分泌物样本有望提供BPD发生的可操作生物标志物,尤其用于风险婴儿的前瞻性分类和及时定制治疗。
研究设计与样本
- 回顾性单中心队列研究,纳入两个独立早产儿队列第3周龄的便利样本。
- 队列1(n=23婴儿)比较口腔分泌物与气管吸出物蛋白质组;队列2(n=17婴儿,含8例BPD)绘制口腔分泌物BPD相关蛋白变化。
- 应用样本节省型高通量蛋白质组学技术分析既往保存样本。
主要发现
- 生命第一个月样本中鉴定出口腔分泌物特有蛋白607种、气管吸出物特有蛋白327种、重叠蛋白687种。
- 重叠蛋白涉及免疫效应过程、中性粒细胞脱颗粒、白细胞介导免疫和代谢过程等通路。
- 鉴定出37种口腔蛋白在BPD病例与对照间丰度显著差异,其中13种与代谢和免疫失调相关。
- 13种中有10种(如SERPINC1、CSTA、BPI)此前基于血液或气管吸出物研究已与BPD或其他早产相关肺病关联,但未在口腔分泌物中报道。
临床怎么用
- 口腔分泌物可作为无创样本替代气管吸出物,用于早产儿呼吸状态追踪和BPD风险预测的蛋白质组学分析。
- 鉴定出的口腔蛋白差异丰度可能有助于BPD风险婴儿的前瞻性分类和及时定制治疗。
局限性
- 回顾性单中心设计,样本为便利样本,队列样本量较小(队列1 n=23,队列2 n=17)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if oral secretions (OS) can be used as a noninvasively collected body fluid, in lieu of tracheal aspirates (TA), to track respiratory status and predict bronchopulmonary dysplasia (BPD) development in infants born <32 weeks. STUDY DESIGN: This was a retrospective, single center cohort study that included data and convenience samples from week-of-life (WoL) 3 from 2 independent preterm infant cohorts. Using previously banked samples, we applied our sample-sparing, high-throughput proteomics technology to compare OS and TA proteomes in infants born <32 weeks admitted to the Neonatal Intensive Care Unit (NICU) (Cohort 1; n = 23 infants). In a separate similar cohort, we mapped the BPD-associated changes in the OS proteome (Cohort 2; n = 17 infants including 8 with BPD). RESULTS: In samples collected during the first month of life, we identified 607 proteins unique to OS, 327 proteins unique to TA, and 687 overlapping proteins belonging to pathways involved in immune effector processes, neutrophil degranulation, leukocyte mediated immunity, and metabolic processes. Furthermore, we identified 37 OS proteins that showed significantly differential abundance between BPD cases and controls: 13 were associated with metabolic and immune dysregulation, 10 of which (eg, SERPINC1, CSTA, BPI) have been linked to BPD or other prematurity-related lung disease based on blood or TA investigations, but not OS. CONCLUSIONS: OS are a noninvasive, easily accessible alternative to TA and amenable to high-throughput proteomic analysis in preterm newborns. OS samples hold promise to yield actionable biomarkers of BPD development, particularly for prospective categorization and timely tailored treatment of at-risk infants with novel therapies.
引用
- Ahmed S, Odumade OA, van Zalm P, et al. Proteomics-Based Mapping of Bronchopulmonary Dysplasia-Associated Changes in Noninvasively Accessible Oral Secretions. J Pediatr. 2023. PMID: 37839510. doi:10.1016/j.jpeds.2023.113774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。